Bloomberg Law’s “Product Safety & Liability Reporter” quotes from Ed Fanning’s arguments before the New Jersey Supreme Court on the issue of the admissibility of expert testimony in the In re: Accutane Litigation. Noting that McCarter appeared on behalf of several business groups that supported Hoffman-La Roche as friend-of-the-court, the report details Ed’s argument regarding the tens of thousands of pharmaceutical cases filed in New Jersey courts by out-of-state plaintiffs and the concern that this number will continue to grow if plaintiffs believe the state has lax rules for expert admissibility that make it a hospitable forum for cases based on unsound science and unreliable expert testimony.
4.30.2018